Mathias Zink

6.8k citations

133 papers · 3.9k indexed · h-index 33

Biological Psychiatry top 0.5%
- Tryptophan and brain disorders 12
Behavioral Neuroscience top 1%
Psychiatry and Mental health top 0.5%
- Schizophrenia research and treatment 75
- Bipolar Disorder and Treatment 22
Cognitive Neuroscience top 2%
- Autism Spectrum Disorder Research 11
Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research 26
Clinical Psychology
- Obsessive-Compulsive Spectrum Disorders 26
Pharmacology
- Treatment of Major Depression 19
Philosophy
- Mental Health and Psychiatry 16

Co-authors: Susanne Englisch Frederike Schirmbeck Fritz A. Henn Andreas Meyer‐Lindenberg Franziska Rausch Andrea Schmitt Peter J. Gebicke‐Haerter Christine Esslinger
Cited by: Biological Psychiatry Behavioral Neuroscience Psychiatry and Mental health
Partner nations: Germany Netherlands United States

In The Last Decade

Mathias Zink

129 papers receiving 3.8k citations

Peers

Countries citing papers authored by Mathias Zink

Since Specialization

Citations

This map shows the geographic impact of Mathias Zink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Zink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Zink more than expected).

Fields of papers citing papers by Mathias Zink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Zink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Zink. The network helps show where Mathias Zink may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mathias Zink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathias Zink Line = papers co-authored together Mathias Zink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysis Hendrik Müller,Linda T. Betz,Joseph Kambeitz,Peter Falkai,Wolfgang Gäebel,Andreas Heinz,Martin Hellmich,Georg Juckel,Martin Lambert,Andreas Meyer‐Lindenberg,Frank Schneider,Michael Wagner,Mathias Zink,Joachim Klosterkötter,Andreas Bechdolf	2022	2
2	<p>Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia</p> Cristina Domènech,Adriana Pastore,A. Carlo Altamura,Corrado Bernasconi,Ricardo Corral,Hélio Elkis,Jonathan Evans,Ashok Malla,Francesco Margari,Marie‐Odile Krebs,Anna-Lena Nordstroem,Mathias Zink,Josep María Haro	2019	11
3	Can the Positive and Negative Syndrome scale (PANSS) differentiate treatment-resistant from non-treatment-resistant schizophrenia? A factor analytic investigation based on data from the Pattern cohort study Rosana Freitas,Bernardo dos Santos,Carlo Altamura,Corrado Bernasconi,Ricardo Corral,Jonathan Evans,Ashok Malla,Marie‐Odile Krebs,Anna-Lena Nordstroem,Mathias Zink,Josep María Haro,Hélio Elkis	2019	11
4	Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study Josep María Haro,Carlo Altamura,Ricardo Corral,Hélio Elkis,Jonathan Evans,Marie‐Odile Krebs,Mathias Zink,Ashok Malla,Ignacio Méndez,Corrado Bernasconi,Justine Lalonde,Anna-Lena Nordstroem	2018	27
5	Health-related quality of life in outpatients with schizophrenia: factors that determine changes over time Cristina Domènech,Carlo Altamura,Corrado Bernasconi,Ricardo Corral,Hélio Elkis,Jonathan Evans,Ashok Malla,Marie‐Odile Krebs,Anna-Lena Nordstroem,Mathias Zink,Josep María Haro	2018	6
6	Obsessive–compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings (unknown),Frederike Schirmbeck,Marije Swets,Carin J. Meijer,Mathias Zink,Lieuwe de Haan	2016	16
7	Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial Brooke C. Schneider,Martin Brüne,Francesca Bohn,Ruth Veckenstedt,Katharina Kolbeck,Eva Krieger,A. Becker,Kim Alisha Drommelschmidt,Susanne Englisch,Sarah Eisenacher,Sie-In Lee-Grimm,Matthias Nagel,Mathias Zink,Steffen Moritz	2016	9
8	Clinical high risk for psychosis: gender differences in symptoms and social functioning Liz Rietschel,Martin Lambert,Anne Karow,Mathias Zink,Hendrik Müller,Andreas Heinz,Walter de Millas,Birgit Janssen,Wolfgang Gäebel,Frank Schneider,Dieter Naber,Georg Juckel,Seza Krüger‐Özgürdal,Thomas Wobrock,Michael Wagner,Wolfgang Maier,Joachim Klosterkötter,Andreas Bechdolf,(unknown)	2015	52
9	Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia A. Schreiner,Kaire Aadamsoo,A.C. Altamura,Manuel Franco,Philip Gorwood,Nikolaj G. Neznanov,Juan Schronen,Alp Üçok,Mathias Zink,Adam Janik,P. Chérubin,Marjolein Lahaye,L. Hargarter	2015	115
10	Investigation of metamemory functioning in the at-risk mental state for psychosis Sarah Eisenacher,Franziska Rausch,Fabian Ainser,Daniela Mier,Ruth Veckenstedt,Frederike Schirmbeck,Antje Lewien,Susanne Englisch,Christina Andreou,Steffen Moritz,Andreas Meyer‐Lindenberg,Peter Kirsch,Mathias Zink	2015	30
11	The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity Franziska Rausch,Sarah Eifler,Andrea Esser,Christine Esslinger,Frederike Schirmbeck,Andreas Meyer‐Lindenberg,Mathias Zink	2013	29
12	Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment Martina von Wilmsdorff,Carolin Blaich,Mathias Zink,Jens Treutlein,Manfred Bauer,Thomas G. Schulze,Neil Thomas,Oliver Gruber,Marcella Rietschel,Andrea Schmitt,Peter Falkai	2012	15
13	Stable Cognitive Deficits in Schizophrenia Patients With Comorbid Obsessive-Compulsive Symptoms: A 12-Month Longitudinal Study Frederike Schirmbeck,Franziska Rausch,Susanne Englisch,Sarah Eifler,Christine Esslinger,Andreas Meyer‐Lindenberg,Mathias Zink	2012	50
14	Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients Christine Esslinger,Susanne Englisch,Dragoš Inta,Franziska Rausch,Frederike Schirmbeck,Daniela Mier,Peter Kirsch,Andreas Meyer‐Lindenberg,Mathias Zink	2012	80
15	Polypharmacy in schizophrenia Mathias Zink,Susanne Englisch,Andreas Meyer‐Lindenberg	2010	110
16	Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial Susanne Englisch,Udo Knopf,Barbara Scharnholz,A. Kuwilsky,Michael Deuschle,Mathias Zink	2008	17
17	Duloxetine Treatment of Major Depressive Episodes in the Course of Psychotic Disorders Mathias Zink,Udo Knopf,E. Mase,A. Kuwilsky,Michael Deuschle	2006	2
18	Mice with Genetically Altered Glucocorticoid Receptor Expression Show Altered Sensitivity for Stress-Induced Depressive Reactions Stephanie Ridder,Sabine Chourbaji,Rainer Hellweg,Alexandre Urani,Christiane Zacher,Wolfgang Schmid,Mathias Zink,Heide Hörtnagl,Herta Flor,Fritz A. Henn,Günther Schütz,Peter Gass	2005	327
19	Ethanol induces GAD67 and VGAT in slice cultures of newborn rat cerebral cortex Mathias Zink,Rainer Spanagel	2005	5
20	Remission of polydipsia as antipsychotic effect of clozapine Mathias Zink,Alexander Sartorius,Florian Lederbogen	2004	7

About Mathias Zink

Mathias Zink is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Clinical Psychology, having authored 133 papers that have together received 3.9k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (75 papers), Obsessive-Compulsive Spectrum Disorders (26 papers), Neuroscience and Neuropharmacology Research (26 papers), Bipolar Disorder and Treatment (22 papers), Treatment of Major Depression (19 papers), Mental Health and Psychiatry (16 papers), Tryptophan and brain disorders (12 papers) and Autism Spectrum Disorder Research (11 papers). The work is most often cited by research in Biological Psychiatry (521 citations), Behavioral Neuroscience (445 citations) and Psychiatry and Mental health (1.8k citations). Mathias Zink has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Susanne Englisch, Frederike Schirmbeck, Fritz A. Henn, Andreas Meyer‐Lindenberg, Franziska Rausch, Andrea Schmitt, Peter J. Gebicke‐Haerter, Christine Esslinger, Sabine Chourbaji and Alexandre Urani.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact